Alterola Biotech (ABTI) Stock Price, News & Analysis
Company Description
Alterola Biotech (OTC Link: ABTI) is classified in the drug manufacturers - specialty & generic industry within the Healthcare sector and carries a market capitalization of $7.4M.
ABTI has gained 0.0% over the past year. Shares last traded at $0.0002.
This page collects what Stock Titan holds for ABTI, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Alterola Biotech (ABTI) stock last closed at $0.0002. Over the past 12 months, the stock has gained 0.0%. At a market capitalization of $7.4M, ABTI is classified as a micro-cap stock with approximately 1.5B shares outstanding.
Latest News
Alterola Biotech has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 3 with negative movement. Key topics include management, acquisition. View all ABTI news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Alterola Biotech (ABTI) currently stands at 10 shares.
Days to Cover History
Days to cover for Alterola Biotech (ABTI) currently stands at 1.0 days, down 99.9% from the previous period. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The days to cover has decreased 99.9% over the past year, suggesting improved liquidity for short covering. The ratio has shown significant volatility over the period, ranging from 1.0 to 1000.0 days.
ABTI Company Profile & Sector Positioning
Alterola Biotech (ABTI) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing ABTI often look at related companies in the same sector, including Canaquest Medica (CANQF), Hempamericana (HMPQ), Indoor Harvest (INQD), Arev Life Sciences Global Corp (AREVF), and Lowell Farms (LOWLF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate ABTI's relative position within its industry.